Acute effects of exogenous nitric oxide on glucose uptake in skeletal muscle of normoglycaemic and diabetic rats

Medical Science Monitor

Volumn 12, Issue 1, 2006, Pages

  McGrowder, Donovan ^a   Ragoobirsingh, Dalip ^a   Brown, Paul ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Glucose uptake; Insulin; Nitric oxide; S nitroso N acetylpenicillamine; S nitrosoglutathione; Skeletal muscle

Indexed keywords

DEOXYGLUCOSE; INSULIN; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; S NITROSOGLUTATHIONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; INCUBATION TIME; LIQUID SCINTILLATION COUNTING; MALE; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RADIOACTIVITY; RAT; RAT STRAIN; SCINTILLATION COUNTING; SKELETAL MUSCLE;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLUCOSE; INSULIN; MALE; MUSCLE, SKELETAL; NITRIC OXIDE; NITRIC OXIDE DONORS; RATS; RATS, SPRAGUE-DAWLEY; S-NITROSO-N-ACETYLPENICILLAMINE; S-NITROSOGLUTATHIONE;

EID: 30944449454     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Moncada S, Higgs A: The L-arginine-nitric oxides pathway. N Eng J Med, 1993; 329: 2002-12
2. Roy D, Perreault M, Marette A: Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol, 1998; 274: E692-E699
3. Bergandi L, Silvagno F, Russo I et al: Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 2003; 23: 2215-21
4. Balon TW, Nadler JL: Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol, 1997; 82(1): 359-63
5. Etgen GJ, Fryburg DA, Gibbs EM: Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3- kinase-independent pathway. Diabetes, 1997; 46: 1915-19
6. Young ME, Leighton B: Fuel oxidation in skeletal muscle is increased by nitric oxide/cGMP-evidence for involvement of cGMP-dependent protein kinase. FEBS Lett, 1998; 424: 79-83
7. Bedard UV, Marcotte B, Marette A: Cytokines modulates glucose transport in skeletal muscle by inducing nitric oxide synthase. Biochem J, 1997; 325: 487-93
8. Bedard UV, Marcotte B, Marette A: Insulin inhibits inducible nitric oxide synthase in skeletal muscle cells. Diabetologia, 1998; 41: 1523-27
9. Perreault M, Marette A: Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med, 2001; 7: 1138-43
10. Ragoobirsingh D, McGrowder D, Dasgupta T, Brown P: The effect of nitric oxide on glucose metabolism. Molecular and Cellular Biochemistry, 2004; 263: 29-34
11. McGrowder D, Ragoobirsingh D, Dasgupta T: Decreased insulin binding to mononuclear leucocytes and erythrocytes from dogs after S-Nitroso-N- acetylpenicillamine administration. BioMed Central Biochemistry, 2002; 3: 1
12. Masiello P, Broca C, Gross R et al: Experimental NIDDM: Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes, 1998; 47: 224-29
13. World Health Organization (WHO): Definition, diagnosis and classification of diabetes mellitus Part 1: diagnosis and classification of diabetes mellitus. Department of non-communicable disease surveillance. Geneva, 1999
14. Hansen PA, Gulve EA, Holloszy JO: Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J Appl Physiol, 1994; 76: 979-85
15. Hart TW: Some observations concerning the S-nitroso and S-phenylsulfonyl derivatives of L-cysteine and glutathione. Tetrahedron Lett, 1985; 26: 2013-16
16. Field L, Dilts RV, Ravichandran R, Lenhert PG: An unusually stable thionitrite from N-acetyl-D,L-penicillamine; X-ray crystal and molecular structure of 2-(acetylamino)-2-carboxy-1,1-dimethylethyl thionitrite. J Chem Soc Chem Commun, 1978; 249-250
17. Bradford MM: A rapid and sensitive method for the quantification of microgram quantities of protein, utilizing the principle of protein-dye binding. Anal Biochem, 1976; 72: 248-54
18. Kahn BB, Rossetti L, Lodish HF, Charron MJ: Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats. J Clin Invest, 1991; 87: 2197-206
19. Gross SS, Wolin MS: Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol, 1995; 57: 737-69
20. Young ME, Radda GK, Leighton B: Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem J, 1997; 322: 223-28
21. Kapur S, Bedard S, Marcotte B et al: Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes, 1997; 46: 1691-700
22. Emani S, Perry MC: A comparison of the effects of sodium and insulin on the control of metabolism in rat isolated adipocytes. Biochem Biophys Acta, 1984; 804: 77-88
23. Lander HM, Sehajpal P, Levine DM, Novogrodsky A: Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J Immunol, 1993; 150: 1509-16
24. Depre C, Gaussin V, Ponchaut S et al: Inhibition of myocardial glucose uptake by cGMP. Am J Physiol Heart Circ Physiol, 1998; 274: H1443-H1449
25. Tada H, Thompson CI, Reechia FA et al: Myocardial glucose uptake is regulated by nitric oxide via endothelial nitric oxide synthase in Langendorff mouse heart. Cir Res, 2000; 86: 270-74
26. Higaki Y, Hirshman MF, Fujii N, Goodyear LJ: Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes, 2001; 50: 241-47
27. Shepherd PR, Withers DJ, Siddle K: Phosphoinositide 3-kinase: the key switch mechanism in insulin signaling. Biochem Journal, 1998; 333: 417-90
28. Garvey WT, Maianu L, Huecksteadt TP et al: Pretranslational suppression of GLUT4 glucose transporters causes insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. J Clin Invest, 1991; 87: 1072-81
29. Kim Y-B, Nikoulina SE, Ciaraldi TP et al: Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinasein muscle in type 2 diabetes. J Clin Invest, 1999; 104: 733-41
30. Smith U, Axelsen M, Carvalho E et al: Insulin signaling and action in fat cells: associations with insulin resistance and type 2 diabetes. Ann NY Acad Sci, 1999; 892: 119-26
31. Carvalho-Filho MA, Ueno M, Hirabara SM et al: S-Nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt - A novel mechanism of insulin resistance. Diabetes, 2005; 54: 959-67
32. McGrowder D, Ragoobirsingh D, Dasgupta T: The hyperglycaemic effect of s-Nitrosoglutathione in the dog. Journal of Nitric Oxide - Biology and Chemistry, 1999; 3: 481-91
33. McGrowder D, Ragoobirsingh D, Dasgupta T: Effects of S-Nitroso-N- acetylpenicillamine administration on glucose tolerance and plasma levels of insulin and glucagon in the dog. Journal of Nitric Oxide - Biology and Chemistry, 2001; 5: 402-12
34. Maccarrone M, Putti S, Finazzi AA: Nitric oxide donors activate the cyclo-oxygenase and peroxidase activities of prostaglandin H synthase. FEBS Lett, 1997; 410: 470-76
35. Sugita H, Sugita M, Kaneki M: iNOS gene disruption restores depressed IRS-1 expression in skeletal muscle and ameliorates insulin resistance in (ob/ob) mice. Diabetes, 2003; 52(Suppl.1): A299
36. Cheatham B, Vlahos CJ, Wang L et al: Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, glucose transporter translocation. Mol Cell Biol, 1994; 14: 4902-11
37. Lund S, Holman GD, Schmitz O, Pedersen O: Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA, 1995; 92: 5817-21
38. Pryor WA, Squadrito GL: The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide. Am J Physiol, 1995; 268: L699-L772
39. Wedgwood S, McMullan M, Bekker J et al: Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Cir Res, 2001; 89: 357-364
40. Soriano FG, Virag L, Jagtap P et al: Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nature Med, 2001; 7: 108-13
41. Suarez-Pinton WL, Szabo C, Rabinovitch A: Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic beta-cells. Diabetes, 1997; 46: 907-11
42. Szabo C, Cuzzocrea S, Zingarelli B et al: Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly(ADP-ribose) synthetase by peroxynitrite. J Clin Invest, 1997; 100: 723-35
43. Szabo C, Mabley JG, Moeller SM et al: Part I: Pathogenesis of peroxynitrite in the development of diabetes and diabetic vascular complications: Studies with FR15, A novel potent peroxynitrite decomposition catalyst. Molecular Medicine, 2002; 8: 571-80
44. Zierath J, Houseknecht KL, Gnudi L, Khan BB: High-fat feeding impairs insulin-stimulated GLUT 4 recruitment via an early insulin signaling defect. Diabetes, 1997; 46: 215-23
45. Corsetti JP, Sparks JD, Peterson RG et al: Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats. Atherosclerosis, 200; 148: 231-41